Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety.

Abstract:

:This is the second of two papers which review issues concerning complementary medicines. The first reviewed the extent of use of complementary medicines, and issues related to the regulation and pharmaceutical quality of these products; the second considers evidence for the efficacy of several well-known complementary medicines, and discusses complementary-medicines pharmacovigilance. The term complementary medicines describes a range of pharmaceutical-type preparations, including herbal medicines, homoeopathic remedies, essential oils and dietary supplements, which mainly sit outside conventional medicine. The use of complementary medicines is a popular healthcare approach in the UK, and there are signs that the use of such products is continuing to increase. Patients and the public use complementary medicines for health maintenance, for the treatment or prevention of minor ailments, and also for serious, chronic illnesses. There is a growing body of evidence from randomized controlled trials and systematic reviews to support the efficacy of certain herbal extracts and dietary supplements in particular conditions. However, many other preparations remain untested. Strictly speaking, evidence of efficacy (and safety) for herbal medicines should be considered to be extract specific. Pharmacovigilance for complementary medicines is in its infancy. Data are lacking in several areas relevant to safety. Standard pharmacovigilance tools have additional limitations when applied to investigating safety concerns with complementary medicines.

journal_name

Br J Clin Pharmacol

authors

Barnes J

doi

10.1046/j.1365-2125.2003.01811.x

keywords:

subject

Has Abstract

pub_date

2003-04-01 00:00:00

pages

331-40

issue

4

eissn

0306-5251

issn

1365-2125

pii

1811

journal_volume

55

pub_type

杂志文章,评审
  • Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers.

    abstract::1. Ototoxicity is a common and troublesome side-effect of high-dose aspirin treatment but there has been little previous study of the relationships between the degree of ototoxicity and the plasma concentrations of salicylate. 2. In order to investigate the relationships between aspirin dose, total and unbound plasma ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1989.tb03562.x

    authors: Day RO,Graham GG,Bieri D,Brown M,Cairns D,Harris G,Hounsell J,Platt-Hepworth S,Reeve R,Sambrook PN

    更新日期:1989-12-01 00:00:00

  • The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.

    abstract::1. The antihypertensive efficacy and tolerability of a low dose combination of the angiotensin converting enzyme inhibitor ramipril (2.5 mg) and the extended release formulation of the dihydropyridine calcium channel antagonist felodipine (5 mg) were assessed in a double-blind, double dummy placebo controlled, randomi...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1993.tb00371.x

    authors: Bainbridge AD,Macfadyen RJ,Stark S,Lees KR,Reid JL

    更新日期:1993-10-01 00:00:00

  • Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.

    abstract:AIMS:To predict the drug interactions of amiodarone and other drugs, the inhibitory effects and inactivation potential for human cytochrome P450 (CYP) enzymes by amiodarone and its N-dealkylated metabolite, desethylamiodarone were examined. METHODS:The inhibition or inactivation potency of amiodarone and desethylamiod...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.2000.00134.x

    authors: Ohyama K,Nakajima M,Suzuki M,Shimada N,Yamazaki H,Yokoi T

    更新日期:2000-03-01 00:00:00

  • Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.

    abstract::1 The effect of an intravenous bolus of labetalol (0.6-1.6 mg/kg body weight) on central and peripheral haemodynamics was studied in nine subjects with essential hypertension and in eleven subjects with chronic renal disease and hypertension. 2 The BP reduction amounting to 20/13 mmHg was entirely due to the lowering ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1979.tb04764.x

    authors: Bahlmann J,Brod J,Hubrich W,Cachovan M,Pretschner P

    更新日期:1979-04-01 00:00:00

  • Paracetamol metabolism in pregnancy.

    abstract::Paracetamol disposition was studied in groups of pregnant and non-pregnant women of comparable age. Paracetamol apparent oral clearance was 58% higher and elimination half-life was 28% lower in the pregnant women compared to the control group. The higher clearance in the pregnant women was due to increased activity of...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1986.tb02901.x

    authors: Miners JO,Robson RA,Birkett DJ

    更新日期:1986-09-01 00:00:00

  • Comparison of the acute vascular effects of frusemide and bumetanide.

    abstract::The acute peripheral vascular and diuretic effects of intravenous frusemide 10 mg and 20 mg were compared with those of bumetanide 250 micrograms and 500 micrograms in a group of 10 salt depleted volunteers. Significant reductions in forearm blood flow (FBF) were observed after frusemide 10 mg (-0.77 ml 100 ml-1 min-1...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1986.tb05207.x

    authors: Johnston GD,Nicholls DP,Kondowe GB,Finch MB

    更新日期:1986-04-01 00:00:00

  • Potassium supplements during long-term thiazide therapy for essential hypertension.

    abstract::Increasing doses of a slow-release potassium supplement were given to nine hypertensive patients previously treated for at least 18 months with bendrofluazide 10 mg daily. Serum potassium and total body potassium (TBK) were measured after 2 months on each dose. No significant increase in serum potassium or TBK occurre...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1982.tb01975.x

    authors: Wilkinson PR,Tait C,Hesp R,Raftery EB

    更新日期:1982-08-01 00:00:00

  • Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine.

    abstract:WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT:Rotigotine transdermal patch is a new non-ergolinic dopamine agonist developed for the treatment of Parkinson's disease and restless legs syndrome. Peripheral dopaminergic side-effects of dopamine agonists such as nausea and vomiting can be prevented by the antiemetic agent domp...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.2008.03334.x

    authors: Braun M,Cawello W,Boekens H,Horstmann R

    更新日期:2009-02-01 00:00:00

  • Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation.

    abstract:AIMS:The study was designed to evaluate the relative bioavailability of diclofenac in plasma, subcutaneous adipose and skeletal muscle tissue after repeated topical administration using MIKA Diclofenac Spray Gel (4%), a novel formulation, and after oral dosing using VOLTAREN 50 mg enteric coated tablets. METHODS:Diclo...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2005.02484.x

    authors: Brunner M,Dehghanyar P,Seigfried B,Martin W,Menke G,Müller M

    更新日期:2005-11-01 00:00:00

  • Patients compliance in hypertension--the importance of number of tablets.

    abstract::The importance of number of tablets for patient compliance was investigated in 160 patients with mild-moderate essential hypertension treated with a beta-adrenoceptor blocker and a thiazide diuretic. Mean BP at entry 146 +/- 16/92 +/- 8 mm Hg. All patients were given pindolol 10 mg and clopamide 5 mg in one combinatio...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1984.tb02388.x

    authors: Asplund J,Danielson M,Ohman P

    更新日期:1984-05-01 00:00:00

  • Live attenuated polio vaccine and the risk of intussusception.

    abstract:AIMS:Since suspicion has been raised that administration of an oral live attenuated rotavirus vaccine may increase the risk of intussusception in young children, there has been concern about the possible effects of oral polio vaccine. The aim of the study was to evaluate the relationship between oral attenuated polio v...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.2001.00090.x

    authors: Jick H,Vasilakis-Scaramozza C,Jick SS

    更新日期:2001-10-01 00:00:00

  • The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

    abstract:AIMS:To estimate the rates of common adverse events in patients treated with the proton pump inhibitors omeprazole, lansoprazole and pantoprazole in general practice in England. METHODS:In prescription-event monitoring cohort studies, data on dispensed prescriptions prescribed by general practitioners in England soon ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.2000.00262.x

    authors: Martin RM,Dunn NR,Freemantle S,Shakir S

    更新日期:2000-10-01 00:00:00

  • New-onset epilepsy in the elderly.

    abstract::People who are 60 years old and older have the highest incidence of developing new-onset epilepsy. The increase of the ageing population has resulted in a greater number of patients with new-onset epilepsy or at risk of developing the condition. Previously published review articles regarding epilepsy in older patients...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/bcp.13653

    authors: Vu LC,Piccenna L,Kwan P,O'Brien TJ

    更新日期:2018-10-01 00:00:00

  • Efficacy gap between phase II and subsequent phase III studies in oncology.

    abstract:AIMS:There is a trend for more flexibility in timing of evidence generation in relation to marketing authorization, including the option to complete phase III trials after authorization or not at all. This paper investigated the relation between phase II and III clinical trial efficacy in oncology. METHODS:All oncolog...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.14237

    authors: Vreman RA,Belitser SV,Mota ATM,Hövels AM,Goettsch WG,Roes KCB,Leufkens HGM,Mantel-Teeuwisse AK

    更新日期:2020-07-01 00:00:00

  • High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids.

    abstract:AIMS:The inhaled allergen challenge model has been used previously to investigate the effects of novel anti-inflammatory drugs in inhaled corticosteroid (ICS)-naïve asthmatics. The aim of this study was to characterize high- and low-dose allergen challenges in asthmatic patients using ICS. METHODS:Twenty-eight asthmat...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.12508

    authors: Lee WY,Southworth T,Booth S,Singh D

    更新日期:2015-03-01 00:00:00

  • Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia.

    abstract:AIMS:Previous studies of the prescription patterns of psychotropic medications in patients with schizophrenia have highlighted a high rate of antipsychotic polypharmacy, but data in Asia are sparse. This study seeks to examine the prevalence of antipsychotic polypharmacy in patients with schizophrenia and compare the d...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,多中心研究

    doi:10.1111/j.1365-2125.2004.02102.x

    authors: Sim K,Su A,Fujii S,Yang SY,Chong MY,Ungvari GS,Si T,Chung EK,Tsang HY,Chan YH,Heckers S,Shinfuku N,Tan CH

    更新日期:2004-08-01 00:00:00

  • Oxidative activation of proguanil and dapsone acetylation in Thai soldiers.

    abstract::The prevalence of putative poor metaboliser (PM) phenotypes of proguanil oxidation in Caucasian populations is 3-10%. The PM frequency in Oriental populations is unknown. In this study the plasma metabolic ratios of proguanil and dapsone to their principal metabolites cycloguanil and monoacetyldapsone were determined ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1994.tb04241.x

    authors: Edstein MD,Shanks GD,Teja-Isavadharm P,Rieckmann KH,Webster HK

    更新日期:1994-01-01 00:00:00

  • Usage of paracetamol-containing combination analgesics remains high in primary care.

    abstract:AIMS:Paracetamol-containing combination analgesics are widely prescribed but the use of paracetamol/dextropropoxyphene (co-proxamol) is particularly controversial. We aim to examine the prescribing patterns of the paracetamol-containing analgesics in Ireland. METHODS:A national primary care prescribing database was us...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,多中心研究

    doi:10.1111/j.1365-2125.2005.02500.x

    authors: Usher C,Teeling M,Bennett K,McGowan B,Feely J

    更新日期:2005-12-01 00:00:00

  • Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers.

    abstract:AIM:To assess the effect of Schisandra sphenanthera extract (SchE) on the pharmacokinetics of tacrolimus in healthy volunteers. METHODS:Twelve healthy male volunteers were orally treated with SchE, three capsules twice daily for 13 days. Pharmacokinetic investigations of oral tacrolimus administration at 2 mg were per...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2007.02922.x

    authors: Xin HW,Wu XC,Li Q,Yu AR,Zhu M,Shen Y,Su D,Xiong L

    更新日期:2007-10-01 00:00:00

  • Flecainide: single and multiple oral dose kinetics, absolute bioavailability and effect of food and antacid in man.

    abstract::The kinetics of flecainide after single intravenous (2 mg kg-1) and oral (200 mg) dosing, absolute bioavailability, effects of food and aluminium hydroxide on flecainide absorption and steady-state kinetics following twice daily oral dosing (200 mg) have been evaluated in ten healthy subjects. Absolute bioavailability...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1986.tb02892.x

    authors: Tjandra-Maga TB,Verbesselt R,Van Hecken A,Mullie A,De Schepper PJ

    更新日期:1986-09-01 00:00:00

  • Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapen.

    abstract::1. A rapid intravenous bolus injection of 4.0 g Magnapen (which contains 2.0 g of ampicillin and 2.0 g of flucloxacillin) was to seven patients undergoing total hip replacement immediatly before induction of general anesthesia. Postoperatively the patients patients received 2.0 g Magnapen by intramuscular injection ev...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1978.tb00838.x

    authors: Parsons RL,Beavis JP,Laurence M,David JA,Paddock GM,Trounce JR

    更新日期:1978-08-01 00:00:00

  • In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6.

    abstract:AIMS:To examine the potency of ticlopidine (TCL) as an inhibitor of cytochrome P450s (CYP450s) in vitro using human liver microsomes (HLMs) and recombinant human CYP450s. METHODS:Isoform-specific substrate probes of CYP1A2, 2C19, 2C9, 2D6, 2E1 and 3A4 were incubated in HLMs or recombinant CYPs with or without TCL. Pre...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.2000.00175.x

    authors: Ko JW,Desta Z,Soukhova NV,Tracy T,Flockhart DA

    更新日期:2000-04-01 00:00:00

  • Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis.

    abstract:AIMS:The aim of the present study was to assess the effect of policy interventions - i.e. reimbursement decisions, guidelines and regional recommendations - on the prescribing of oral anticoagulant treatment in patients with atrial fibrillation (AF). METHODS:Interrupted time series analyses were carried out using mont...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.13150

    authors: Komen J,Forslund T,Hjemdahl P,Andersen M,Wettermark B

    更新日期:2017-03-01 00:00:00

  • Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients.

    abstract:AIMS:Naloxegol, a polyethylene glycol conjugated derivative of the opioid antagonist naloxone, is in clinical development for treatment of opioid-induced constipation (OIC). The aim of the study was to develop a population pharmacokinetic model describing the concentration vs. time profile of orally administered naloxe...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.12756

    authors: Al-Huniti N,Chapel S,Xu H,Bui KH,Sostek M

    更新日期:2016-01-01 00:00:00

  • Some effects of mianserin on monoamine metabolism in the rat brain.

    abstract::1 Mianserin does not affect the uptake of biogenic amines into rat brain, in contrast to tricyclic antidepressants which block amine uptake. 2 Mianserin increases the turnover of noradrenaline (NA) in rat brain after acute or chronic administration, whereas tricyclic antidepressants reduce turnover of NA and 5-hydroxy...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:

    authors: Leonard BE

    更新日期:1978-01-01 00:00:00

  • Tolerance and safety of enalapril.

    abstract::Enalapril is the result of a targeted research programme to develop a non-mercapto converting enzyme inhibitor with a long duration of action and an improved safety profile for use in the therapy of hypertension and congestive heart failure. Over 3500 patients world-wide have received enalapril or enalaprilat. Long-te...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1984.tb02604.x

    authors: McFate Smith W,Davies RO,Gabriel MA,Kramsch DM,Moncloa F,Rush JE,Walker JF

    更新日期:1984-01-01 00:00:00

  • Pupillary response to topical tropicamide as a marker for Alzheimer's disease.

    abstract::The mydriatic response to eyedrops of the anticholinergic drug tropicamide at very low concentration (0.01%) was studied in subjects with Alzheimer's disease (AD, n = 10) and multi-infarct dementia (MID, n = 10). There was no significant difference in pupillary response between the two groups. The test is unlikely to ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1996.tb00194.x

    authors: Treloar AJ,Assin M,Macdonald AJ

    更新日期:1996-03-01 00:00:00

  • Lisinopril population pharmacokinetics in elderly and renal disease patients with hypertension.

    abstract::1. The population pharmacokinetics of lisinopril were investigated using data collected from two multicentre trials of lisinopril in the treatment of hypertension in elderly patients (n = 40) and patients with renal disease (n = 20). 2. Lisinopril was started at doses of 2.5-5 mg daily and increased at 2-4 weekly inte...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1989.tb05335.x

    authors: Thomson AH,Kelly JG,Whiting B

    更新日期:1989-01-01 00:00:00

  • The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.

    abstract::The degrees of interactions between the H2-receptor antagonists, cimetidine and ranitidine, and several beta-adrenoceptor blockers were investigated in healthy volunteers following 7 days of oral monotherapy with penbutolol, propranolol, metoprolol, pindolol and atenolol, and after co-administration with each of the H...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1984.tb02428.x

    authors: Mutschler E,Spahn H,Kirch W

    更新日期:1984-01-01 00:00:00

  • Phytonutrients for bone health during ageing.

    abstract::Osteoporosis is a skeletal disease characterized by a decrease in bone mass and bone quality that predispose an individual to an increased risk of fragility fractures. Evidence demonstrating a positive link between certain dietary patterns (e.g. Mediterranean diet or high consumption of fruits and vegetables) and bone...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/bcp.12033

    authors: Sacco SM,Horcajada MN,Offord E

    更新日期:2013-03-01 00:00:00